Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

97.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hypomagnesemia and its clinical outcome: a prospective observational study in a tertiary care hospital in Bangladesh.

Annals of medicine and surgery (2012)·2026
Same author

Comparative Molecular Profiling of Basal Cell Carcinomas in Sun-Exposed and Anogenital Regions.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026
Same author

Immunotherapy in pediatric bone sarcomas: Current progress and future directions.

Human vaccines & immunotherapeutics·2026
Same author

Challenges of chimerism analysis using Next-Generation sequencing in a patient with complex chromosomal alterations.

Human immunology·2026
Same author

The registration status of maternal, newborn, and child health medical products: evidence from 9 countries.

Journal of pharmaceutical policy and practice·2026
Same author

Single-Cell RNA Analysis of Murine Osteosarcoma Uncovers Skp2 Function in Metastasis, Genomic Instability, and Immune Activation and Reveals Additional Target Pathways.

Cancer research communications·2026

相关实验视频

Updated: Jan 9, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K

通过下一代测序来高度灵敏地检测捐赠者化学反应.

Eros Qama1, Abedul Haque1, Juan Du1

  • 1Department of Pathology, Montefiore Medical Center, Bronx, New York.

The Journal of molecular diagnostics : JMD
|November 30, 2025
PubMed
概括

这项研究验证了One Lambda Devyser基因组测试,这是一种敏感的下一代测序测试,用于在干细胞移植后监测供体基因组. 它准确地检测到低水平的受体DNA,有助于早期发现复发.

更多相关视频

A Semiautomated ChIP-Seq Procedure for Large-scale Epigenetic Studies
08:04

A Semiautomated ChIP-Seq Procedure for Large-scale Epigenetic Studies

Published on: August 13, 2020

3.9K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

6.5K

相关实验视频

Last Updated: Jan 9, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K
A Semiautomated ChIP-Seq Procedure for Large-scale Epigenetic Studies
08:04

A Semiautomated ChIP-Seq Procedure for Large-scale Epigenetic Studies

Published on: August 13, 2020

3.9K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

6.5K

科学领域:

  • 血液学 血液学 血液学
  • 分子诊断学 分子诊断学
  • 遗传学 是一个遗传学.

背景情况:

  • 供体嵌合体分析对于监测移植和复发风险在异构干细胞移植后至关重要.
  • 下一代测序 (NGS) 试验比传统方法 (如毛细管电泳) 提供了更好的灵敏度和准确性.

研究的目的:

  • 为了验证One Lambda Devyser Chimerism测试的性能,这是一个基于NGS的供体化学反应测试.
  • 在多样化的患者群体中评估试验的灵敏度,特异性和可靠性.

主要方法:

  • 使用270个临床和细胞系DNA样本对One Lambda Devyser化学反应试验的验证.
  • 与短串重复 (STR) 试验的相关性分析.
  • 确定分析灵敏度 (空白限值,检测,定量) 和特异性.
  • 评估可复制性,线性和DNA库特征.
  • 在一个由30个主要是非裔美国人和西班牙裔接受者/捐赠者对组成的队列中评估标志物适应性.

主要成果:

  • 一个兰巴达Devyser试验和STR试验之间的高相关性 (R2 = 0.998).
  • 该测试可靠地检测到接受者的DNA分数低至0.1%,显示出高灵敏度.
  • 分析特异性超过99.9%.
  • 在测试的多样化人口中,平均每对确定7个信息标记,相关对5个.

结论:

  • 一个兰巴达Devyser化学化测试是一种高度敏感和准确的NGS基于的工具,用于供体化学化监测.
  • 该试验在低受体DNA度下表现出色,使得早期检测疾病复发成为可能.
  • 在多样化的群体中验证证了其适用于干细胞移植监测的广泛临床应用的适用性.